RecruitingNot ApplicableNCT04848077

STEPWISE Parkinson: A Smartphone Based Exercise Solution for Patients With Parkinson's Disease

STEPWISE Parkinson: A Smartphone Based, Titrated Exercise Solution for Patients With Parkinson's Disease in Daily Life


Sponsor

Radboud University Medical Center

Enrollment

452 participants

Start Date

May 18, 2021

Study Type

INTERVENTIONAL

Conditions

Summary

The aim of this study is to investigate whether a smartphone app can increase physical activity in patients with Parkinson's Disease in daily life for a long period of time (12 months).


Eligibility

Min Age: 18 Years

Inclusion Criteria6

  • idiopathic PD
  • Hoehn and Yahr 1-3
  • able to understand the Dutch language
  • able to walk independently
  • equal to or less than 120 minutes of sports/outdoor activities per day (question 5-28 LASA Physical Activity Questionnaire (LAPAQ))
  • less than 7,000 steps/day during 1-month baseline (week -4 until 0)

Exclusion Criteria5

  • weekly falls in the previous 3 months
  • medical conditions that hamper mobility other than PD
  • living in a nursing home
  • cognitive impairments that hamper use of the motivational app (subjective evaluation by the assessor)
  • not in the possession of a suitable smartphone (Iphone 5S or newer with iOS 10 or higher or Android 4.1 or newer)

Interventions

BEHAVIORALStep count increase with the use of a motivational smartphone application

All participants will be given access to an application installed on the participants' own smartphone: the STEPWISE app. The STEPWISE app will encourage participants to increase their long-term physical activity (1 year). Different treatment arms will receive different physical activity goals. Participants will get feedback and support via the smartphone app, that stimulates them to reach their individual physical activity goal (i.e. target percentage increase in stepcount).


Locations(1)

Radboud university medical center

Nijmegen, Gelderland, Netherlands

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04848077


Related Trials